We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $4.25B
1-Year Est. Return 141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
Cap. Flow
-$109M
Cap. Flow %
-2.57%
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39

Top Buys

Rank Stock Value
1
LGN
Legence Corp
LGN
+$53.3M
2
SXT icon
Sensient Technologies
SXT
+$43.9M
3
IDCC icon
InterDigital
IDCC
+$35.5M
4
ACLS icon
Axcelis
ACLS
+$34.7M
5
TEX icon
Terex
TEX
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Industrials 24.1%
3 Healthcare 21.93%
4 Financials 9.1%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTI icon
51
TETRA Technologies
TTI
$1.03B
$35M 0.82%
3,093,379
+431,852
+16% +$4.23M
AMSC icon
52
American Superconductor
AMSC
$1.41B
$35M 0.82%
843,956
+86,552
+11% +$3.91M
MC icon
53
Moelis & Co
MC
$5.12B
$34.8M 0.82%
531,883
-16,194
-3% -$1.06M
KTOS icon
54
Kratos Defense & Security Solutions
KTOS
$9.03B
$34.8M 0.82%
697,181
-138,748
-17% -$8.39M
OLLI icon
55
Ollie's Bargain Outlet
OLLI
$4.45B
$34.2M 0.8%
444,778
+97,653
+28% +$8.14M
RMBS icon
56
Rambus
RMBS
$9.15B
$33.5M 0.79%
252,693
-240,543
-49% -$31.3M
TRVI icon
57
Trevi Therapeutics
TRVI
$2.43B
$33.5M 0.79%
1,797,611
-41,955
-2% -$610K
ONTO icon
58
Onto Innovation
ONTO
$15.4B
$33.2M 0.78%
87,619
-30,804
-26% -$8.72M
IMAX icon
59
IMAX
IMAX
$2.85B
$33M 0.78%
827,965
-21,183
-2% -$812K
TMDX icon
60
Transmedics
TMDX
$3.02B
$32.6M 0.77%
490,491
+147,700
+43% +$12.5M
RXO icon
61
RXO
RXO
$3.3B
$32.4M 0.76%
1,174,517
+736,046
+168% +$16.3M
PLMR icon
62
Palomar
PLMR
$3.58B
$31.4M 0.74%
248,267
-50,092
-17% -$5.9M
AAOI icon
63
Applied Optoelectronics
AAOI
$8.52B
$31.3M 0.74%
211,574
-222,308
-51% -$36.1M
BJRI icon
64
BJ's Restaurants
BJRI
$1.25B
$31.2M 0.73%
513,574
-17,425
-3% -$762K
TBBK icon
65
The Bancorp
TBBK
$2.76B
$29.9M 0.7%
478,025
-13,315
-3% -$763K
HNGE
66
Hinge Health
HNGE
$7.32B
$29.8M 0.7%
358,655
+79,765
+29% +$4.33M
AVAV icon
67
AeroVironment
AVAV
$7.48B
$29.1M 0.69%
176,383
-3,491
-2% -$625K
CVLT icon
68
Commault Systems
CVLT
$5.68B
$28.1M 0.66%
198,459
+1,318
+0.7% +$142K
MTRN icon
69
Materion
MTRN
$5.01B
$27.6M 0.65%
+92,808
New +$19.4M
QBTS icon
70
D-Wave Quantum Inc
QBTS
$6.26B
$27.5M 0.65%
1,147,775
+607,444
+112% +$13.3M
ARLO icon
71
Arlo Technologies
ARLO
$1.45B
$27.3M 0.64%
2,021,645
+2,716
+0.1% +$36.8K
NKTR icon
72
Nektar Therapeutics
NKTR
$2.61B
$27.2M 0.64%
390,158
-4,446
-1% -$325K
CUBI icon
73
Customers Bancorp
CUBI
$2.69B
$26.5M 0.62%
334,660
-8,549
-2% -$647K
AXSM icon
74
Axsome Therapeutics
AXSM
$10.9B
$25.5M 0.6%
104,237
-3,373
-3% -$731K
BOBS
75
Bobs Discount Furniture
BOBS
$2.15B
$25.4M 0.6%
1,607,068
+262,018
+19% +$3.25M

Similar funds

Emerald Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
  • Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
  • Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
  • Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
  • Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
  • Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.